Defunct Company
Total Trials
26
As Lead Sponsor
8
As Collaborator
18
Total Enrollment
5,530
NCT00038012
rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin
Phase: N/A
Role: Collaborator
Start: Jul 23, 1999
Completion: Jun 30, 2004
NCT00200174
Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease
Start: Jul 31, 1999
Completion: Aug 31, 2008
NCT00628225
Smoking Cessation in Patients With COPD (SMOCC) in General Practice
Phase: Phase 4
Start: Mar 31, 2000
Completion: Dec 31, 2003
NCT00861276
Nicotine Substitute Prescribed at Hourly Intake or ad Libitum for Heavy Smokers Willing to Quit
Start: Jun 30, 2000
Completion: Dec 31, 2001
NCT00582660
Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib
Phase: Phase 2
Start: Dec 31, 2001
Completion: Jun 30, 2008
NCT00137852
Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer
Start: Jan 31, 2002
Completion: Sep 30, 2017
NCT00146588
Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer
Start: Apr 30, 2002
Completion: Dec 31, 2004
NCT00544232
Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)
Phase: Phase 3
Start: Aug 31, 2002
Completion: Sep 30, 2006
NCT00581971
Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer
Phase: Phase 1/2
Start: Sep 30, 2002
Completion: Mar 31, 2012
NCT00062179
Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
Start: Mar 31, 2003
Completion: Nov 30, 2006
NCT00353015
Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract
Completion: Jul 31, 2009
NCT00231829
A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers
Start: Apr 30, 2003
Completion: Mar 31, 2004
NCT00777075
L-Arginine and Erectile Dysfunction
Start: Jul 31, 2003
Completion: Nov 30, 2005
NCT00072319
Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
Start: Aug 31, 2003
NCT00211952
Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients
Start: Mar 31, 2004
Completion: Not specified
NCT00470002
Effects of Growth Hormone on the Nitric Oxide Pathway
Phase: Phase 1
Start: May 31, 2004
Completion: Jan 31, 2005
NCT00612638
Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
Start: Jan 31, 2005
Completion: Jul 31, 2008
NCT01864239
The Medicines Advice Service Evaluation
Start: Nov 30, 2012
Completion: Sep 30, 2014
NCT06367426
A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People
Role: Lead Sponsor
Start: Apr 30, 2024
Completion: May 31, 2025